Litcius/Paper detail

BNT162b2 mRNA COVID-19 Vaccine: First Approval

Yvette N. Lamb

2021Drugs424 citationsDOIOpen Access PDF

Topics & Concepts

MedicineCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Marketing authorizationPandemicAuthorization2019-20 coronavirus outbreakVirologyDiseaseOutbreakBioinformaticsInfectious disease (medical specialty)Internal medicineComputer scienceBiologyComputer securitySARS-CoV-2 and COVID-19 ResearchViral gastroenteritis research and epidemiologyViral Infections and Immunology Research
BNT162b2 mRNA COVID-19 Vaccine: First Approval | Litcius